INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate CAR-T and CAR-NK cells in the patient’s body to target CD20-expressing malignant B cells Interim safety and ...

Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also ...

Cancer is now the top cause of death in the US, with key epigenetic traits providing new avenues for diagnosis and treatment.

Favorable safety profile seen for relapsed/refractory large B-cell lymphoma patients monitored as outpatients or inpatients.

Washington Research Foundation (WRF) has awarded $6 million in grant funding through a new program designed to support late-stage preclinical development and first-in-human clinical trials of novel ...

ADRX-0405 is a novel antibody-drug conjugate targeting STEAP1, and a phase 1a/b study will investigate the agent for the ...

In a report released today, Peter Lawson from Barclays assigned a Buy rating to Nurix Therapeutics (NRIX – Research Report), with a price ...

Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing a new generation of macrocycle therapies, today announced that preclinical data from its lead ...

Alicia Zhou, PhD, became CRI’s president effective August 26, and succeeded Jill O’Donnell-Tormey, PhD, who had led the Institute since 1993.

The human gut is home to helpful microbes, called the microbiota, who produce molecules known as metabolites. These ...

The Blumberg Institute, a nonprofit biotechnology research and education organization focused on finding a cure for hepatitis ...

Maylee Tishner plays four square Thursday at Northwestern Elementary School, along with her mom Kelly, back left, and her ...